SXC enters definitive agreement to acquire PTRx

NewsGuard 100/100 Score

SXC Health Solutions Corp. ("SXC") (NASDAQ: SXCI) (TSX: SXC) announced today that it has entered into a definitive agreement to acquire PTRx, Inc. ("PTRx"), a full-service PBM, and SaveDirectRx, Inc. ("SaveDirectRx"), its exclusive mail-order pharmacy provider, both based in San Antonio. The purchase price of $77 million in cash is to be paid from SXC's existing cash balance, subject to certain customary post-closing adjustments, with an additional $4.5 million subject to the achievement of certain performance targets through 2012.

"We are pleased to welcome PTRx, SaveDirectRx, and their employees into the SXC fold," said Mark Thierer, Chairman and CEO of SXC.  "PTRx has been a client and a partner since 2006, initially as an HCIT client and later the relationship expanded to include PBM services. This transaction is in keeping with our strategy to acquire assets that currently utilize SXC's technology platform and can be easily integrated.  The transaction will allow us to leverage our existing partnership, the PTRx book-of-business, the SaveDirectRx mail volume, and the combined entity's ability to drive mail penetration to contribute to the organic growth of the SXC business."

"PTRx has had a long term, collaborative relationship with SXC and coming together is a natural fit for both of us. The strength of our relationship, combined with the resources that SXC brings to the table, will bring additional opportunities for PTRx and SaveDirectRx clients," said Greg Webb, Chief Executive Officer of both PTRx and SaveDirectRx.

Source: SXC HEALTH SOLUTIONS CORP.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can community pharmacists reduce the incidence of skin cancer?